tradingkey.logo
tradingkey.logo
Buscar

MiniMed Ord Shs (Proposed)

MMED
Añadir a la lista de seguimiento
17.360USD
-0.520-2.91%
Cierre 11-10 16:00(ET)
4.88BCap. mercado
PérdidaP/E TTM

Acerca de MiniMed Ord Shs (Proposed) Compañía

MiniMed Group, Inc. is a global medical technology company that develops, manufactures, and markets a suite of solutions for the management of diabetes. The Company's fully integrated system addresses two key pain points for PWD: health outcomes and complexity of diabetes management. The MiniMed 780G is its flagship AID system, which consists of the components: the MiniMed 780G insulin pump, its second-generation insulin pump offering enhanced functionality and technological integration with other components of its 780G system; the Simplera Sync or Instinct CGM sensor, which are both easy-to-use, fully disposable, two-step insertion sensors; and its SmartGuard dosing algorithm technology, which automatically delivers basal insulin and auto-correction doses every five minutes based on sensor glucose readings and adapts to ongoing changes in user behavior patterns every night. For PWD that choose to manage their diabetes with MDI instead of an insulin pump, it offers Smart MDI system.

Perfil de MiniMed Ord Shs (Proposed)

Símbolo de cotización- -
Nombre de la empresa- -
Fecha de salida a bolsa- -
Director ejecutivo- -
Número de empleados- -
Tipo de seguridad- -
Fin del año fiscal- -
Dirección- -
Ciudad- -
Bolsa de valores- -
País- -
Código postal- -
Teléfono- -
Sitio Web- -
Símbolo de cotización- -
Fecha de salida a bolsa- -
Director ejecutivo- -

Ejecutivos de MiniMed Ord Shs (Proposed)

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Kevin E. Lofton
Mr. Kevin E. Lofton
Independent Chairman of the Board
Independent Chairman of the Board
40.41K
+31.26%
Mr. John Gyurci
Mr. John Gyurci
Chief Accounting Officer, Vice President, Controller
Chief Accounting Officer, Vice President, Controller
39.57K
+61.27%
Ms. Que Dallara
Ms. Que Dallara
Chief Executive Officer, Director
Chief Executive Officer, Director
34.25K
-2478.02%
Mr. Timothy A. (Tim) Wicks
Mr. Timothy A. (Tim) Wicks
Independent Director
Independent Director
25.68K
+45.92%
Mr. Chad Spooner
Mr. Chad Spooner
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
19.24K
-1785.07%
Mr. Ali Dianaty
Mr. Ali Dianaty
Executive Vice President, Chief Product and Technology Officer
Executive Vice President, Chief Product and Technology Officer
18.32K
+60.62%
Mr. David J. Endicott
Mr. David J. Endicott
Independent Director
Independent Director
15.17K
--
Ms. Amy Bricker
Ms. Amy Bricker
Independent Director
Independent Director
11.88K
--
Ms. Gillian Chandrasena
Ms. Gillian Chandrasena
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
7.21K
+24.97%
Mr. Robert A. (Bob) Hopkins
Mr. Robert A. (Bob) Hopkins
Director
Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Kevin E. Lofton
Mr. Kevin E. Lofton
Independent Chairman of the Board
Independent Chairman of the Board
40.41K
+31.26%
Mr. John Gyurci
Mr. John Gyurci
Chief Accounting Officer, Vice President, Controller
Chief Accounting Officer, Vice President, Controller
39.57K
+61.27%
Ms. Que Dallara
Ms. Que Dallara
Chief Executive Officer, Director
Chief Executive Officer, Director
34.25K
-2478.02%
Mr. Timothy A. (Tim) Wicks
Mr. Timothy A. (Tim) Wicks
Independent Director
Independent Director
25.68K
+45.92%
Mr. Chad Spooner
Mr. Chad Spooner
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
19.24K
-1785.07%
Mr. Ali Dianaty
Mr. Ali Dianaty
Executive Vice President, Chief Product and Technology Officer
Executive Vice President, Chief Product and Technology Officer
18.32K
+60.62%

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de MiniMed Ord Shs (Proposed)?

Los cinco principales accionistas de MiniMed Ord Shs (Proposed) son: Mr. Kevin E. Lofton

¿Cuál es la mayor fuente de ganancias de MiniMed Ord Shs (Proposed)?

El 2026Q1, el segmento empresarial CGM generó la ganancia más alta para MiniMed Ord Shs (Proposed), ascendiendo a 431.00M y representando el 51.13% de la ganancia total.
tradingkey.logo
Advertencia de Riesgo: Nuestro sitio web y aplicación móvil solo proporcionan información general sobre ciertos productos de inversión. Finsights no proporciona, y la provisión de dicha información no debe interpretarse como que Finsights proporciona, asesoramiento financiero o recomendación para cualquier producto de inversión.
Los productos de inversión están sujetos a riesgos de inversión significativos, incluida la posible pérdida del monto principal invertido y pueden no ser adecuados para todos. El rendimiento pasado de los productos de inversión no es indicativo de su rendimiento futuro.
Finsights puede permitir que anunciantes o afiliados de terceros coloquen o entreguen anuncios en nuestro sitio web o aplicación móvil o en cualquier parte de los mismos y puede ser compensado por ellos en función de su interacción con los anuncios.
© Derechos de autor: FINSIGHTS MEDIA PTE. LTD. Todos los derechos reservados.